ICON

HumanFirst is a company focused on enhancing patient-centered clinical trials through its advanced precision measures platform, which is recognized as the world's largest AI-powered software-as-a-service solution for improving health outcomes. The platform offers insights and validated evidence data to support biopharmaceutical companies in their drug development processes, enabling them to incorporate digital health technologies, digital biomarkers, and electronic clinical outcome assessments. By providing industry educational tools and facilitating collaboration with research partners, HumanFirst helps biopharma organizations increase research efficiency and accelerate the deployment of innovative treatments. The platform has been utilized by a significant majority of the largest pharmaceutical companies globally, underscoring its role in transforming clinical research and driving the evolution of drug development.

PRA Health Sciences is a prominent global contract research organization that delivers a comprehensive range of clinical development and data solution services to the pharmaceutical and biotechnology sectors. With over 17,000 employees and operations in more than 90 offices across North America, Europe, Asia, Latin America, South Africa, Australia, and the Middle East, PRA has participated in over 3,800 clinical trials and has supported pivotal studies leading to the approval of more than 85 products since 2000. The company operates in two primary segments: Clinical Research and Data Solutions. The Clinical Research segment encompasses various services such as clinical trial management, regulatory affairs, biostatistics, and late-phase services, while the Data Solutions segment provides market intelligence, consulting, and technology-enabled products to the life sciences market. With a history dating back to 1976 and a commitment to excellence, PRA Health Sciences conducts clinical trials across numerous therapeutic areas, including oncology, immunology, and infectious diseases, and is dedicated to advancing healthcare globally.

MedPass International SAS, based in Paris, France, is a leading European medical device contract research organization (CRO) and consultancy specializing in regulatory and reimbursement services. Founded in 1991, the company provides a comprehensive array of strategic consulting, regulatory affairs, clinical operations, biometric services, and legal representation, tailored to meet the specific needs of clients worldwide. MedPass supports the entire lifecycle of medical device development, from preclinical stages through to post-marketing, facilitating the advancement of innovative medical technologies. As of January 2020, MedPass operates as a subsidiary of ICON Public Limited Company.

Accellacare is a clinical research organization that focuses on conducting clinical trials to evaluate the safety and efficacy of new medications. Formerly known as MeDiNova Research, Accellacare serves the pharmaceutical, biotechnology, and medical device industries by offering comprehensive trial services. The company emphasizes patient care, fostering a supportive environment for participants throughout the research process. With a strong emphasis on site network feasibility and centralized process management, Accellacare facilitates quicker study initiation. Additionally, its dedicated patient engagement team plays a crucial role in identifying and recruiting suitable participants through an extensive patient database and targeted outreach campaigns, leading to improved recruitment outcomes for clinical trials.

MolecularMD Corporation is a Portland, Oregon-based company that specializes in developing and commercializing molecular diagnostics for oncology applications. Founded by Brian Druker and Sheridan G. Snyder, the company creates tests that facilitate the selection, monitoring, and management of patients receiving targeted cancer therapies. MolecularMD's assays utilize both established and cutting-edge technologies to deliver highly sensitive and reliable results. These results support the clinical development, regulatory approval, and commercialization of new anticancer agents. Additionally, MolecularMD streamlines the co-development and commercialization of its diagnostic tests, offering services such as clinical trial design, regulatory planning, clinical assay validation, and FDA submission, thereby aiding medical companies in the acceleration of precision medicine development in oncology.

Mapi is the leading Patient-Centered Research company serving academia, life science researchers, and the pharmaceutical industry for over 40 years. Mapi’s commitment to patient-focused research is demonstrated not only by our expertise and nearly four decades of service but also through our direct contribution back to the industry. Mapi is among only a handful of global organizations that is capable of engaging with a patients’ complete ecosystem, their HCPs, Patient Communities, payers, and even regulators. And only Mapi has the unique history to make us the most experienced at interacting with all of them. Mapi was founded in 1974 and was focused on the patient from the very beginning. With our Real-World Evidence and post-approval research services, consulting expertise, and publications to our not-for-profit entity, Mapi has been the leading industry driver toward patient-centered research for nearly four decades.

ClinicalRM is a full-service Contract Research Organization specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. The organization helps customers get their products to market faster with a wide array of research, regulatory and sponsor services within the U.S. and around the globe. From international partnerships and affiliations to government relations and local alliances, ClinicalRM delivers a synergy in the global market with projects spanning the government, academic and commercial marketplaces. The company has a distinct ability to provide boots-on-the-ground and rapid response efforts to global health crises.

PMG Research, Inc. is a clinical research organization based in Winston-Salem, North Carolina, specializing in conducting clinical trials across a wide range of therapeutic areas, including asthma, COPD, diabetes, cardiovascular diseases, and more. Founded in 1979, the company operates an integrated network of clinical research facilities located in multiple cities across the United States, including Tennessee, South Carolina, Illinois, and various locations within North Carolina. PMG Research has extensive experience, having conducted over 7,700 research studies for numerous pharmaceutical sponsors and contract research organizations. The company is dedicated to providing high-quality services to its clients and participants, supported by a team of skilled professionals and purpose-built research sites.

MediMedia Managed Markets provides you with the best strategic expertise available in the industry. Their large staff of managed markets strategists, researchers, MDs, PharmDs, and MPHs, all proven experts in the field, will help.

Aptiv Solutions, Inc. is a clinical research organization that specializes in providing a range of clinical trial services to biotechnology and pharmaceutical companies. The company offers adaptive trial design, simulation, and execution, as well as early phase development consulting and drug development services. In addition to these offerings, Aptiv Solutions provides regulatory compliance consulting, focusing on strategy development, agency advisory, legal representation, and submission management. The organization has therapeutic expertise in oncology, cardiology, dermatology, respiratory conditions, and orphan diseases. Aptiv Solutions also develops AptivAdvantage, an integrated technology platform designed for the implementation and execution of adaptive clinical trials. Founded in 1983 and based in Reston, Virginia, the company has an additional office in Durham, North Carolina. It was formerly known as Averion International Corp. before rebranding in February 2011.

Cross Country Healthcare is a prominent provider of staffing and workforce solutions specifically tailored for the healthcare industry. The company specializes in total talent management services, which encompass strategic workforce solutions, contingent staffing, permanent placement, and advisory services to address various labor-related challenges. It operates primarily through two business segments: the nurse and allied staffing segment, which accounts for the majority of its revenue, focuses on the temporary and permanent placement of travel and local nurses and allied health professionals, along with outsourcing services. The Physician Staffing segment supplies licensed practitioners across a wide range of specialties, including certified registered nurse anesthetists, nurse practitioners, and physician assistants. Through its comprehensive offerings, Cross Country Healthcare aims to assist healthcare organizations in effectively managing their staffing needs.

PriceSpective is a value strategy consultancy that defines, drives, and captures value for pharmaceutical and biotechnology clients in today's complex healthcare environment. The company delivers expert guidance in integrated global pricing, reimbursement and market access strategy with its depth of experience and actively engaged senior leadership. PriceSpective is headquartered in Philadelphia with offices in London, Los Angeles, San Diego, Raleigh and Boston.

Beijing Wits Medical Consulting Company was founded in 1997. The company provides services to global and local pharmaceutical, medical device and biotechnology companies focusing on Phase I to IV Clinical studies. Beijing Wits currently has more than 100 employees, operating from 6 offices in China.

Firecrest Clinical Ltd is a provider of site performance management solutions specifically designed for the pharmaceutical, biotechnology, and medical device industries. The company focuses on enhancing compliance and consistency within clinical trials by offering clinical investigator training and comprehensive study services. By delivering outsourced development services, Firecrest Clinical aims to support pharma companies in optimizing their clinical research processes, thereby improving overall site performance and ensuring adherence to regulatory standards.

Oxford Outcomes is a company that specializes in health outcomes research and consultancy services. It focuses on patient reported outcomes (PRO), health economics, epidemiology, and translation and linguistic validation. By offering these expert services, Oxford Outcomes aims to enhance the understanding of health-related quality of life and improve decision-making in healthcare. The company's work is essential for stakeholders seeking to evaluate the effectiveness of medical treatments and interventions through the lens of patient experiences and outcomes.

Timaq Medical Imaging is a Swiss-based company that specializes in advanced medical imaging services tailored for the pharmaceutical and biotech industries. It provides essential support for clinical trials that involve medical imaging, helping firms navigate the complexities of study design and execution. By offering expertise in imaging techniques, Timaq facilitates the evaluation of drug efficacy and safety, thereby playing a crucial role in the development of new therapies. The company's services are designed to meet the specific needs of its clients in the contract service sector, ensuring high-quality imaging solutions that contribute to the advancement of medical research.

Veeda Laboratories Ltd is a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries.

Prevalere Life Sciences, Inc is a contract research organization, provides consulting and GLP/cGMP compliant analytical testing services.

Barton & Polansky Associates, Inc is specialises in clinical research services for immuno-suppressant drugs.

UCT (U.S.), Inc provides central laboratory services for clinical trials to the pharmaceutical and biotechnology industries.

Pacific Research Associates, Inc is specialising in data management statistical analysis and medical and regulatory consulting.